Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of CytomX Therapeutics Inc (NASDAQ: CTMX) closed at $0.97 in the last session, up 0.54% from day before closing price of $0.96. In other words, the price has increased by $0.54 from its previous closing price. On the day, 2.35 million shares were traded.
Ratios:
We take a closer look at CTMX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.25 and its Current Ratio is at 1.25.
On May 28, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $2.25 to $3.50.
Wedbush Upgraded its Neutral to Outperform on May 09, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 18 ’25 when McCarthy Sean A. sold 37,656 shares for $0.60 per share. The transaction valued at 22,556 led to the insider holds 995,195 shares of the business.
Ogden Christopher sold 8,551 shares of CTMX for $5,122 on Mar 18 ’25. The Chief Financial Officer now owns 201,026 shares after completing the transaction at $0.60 per share. On Mar 18 ’25, another insider, Chu Yu-Waye, who serves as the Chief Medical Officer of the company, sold 4,025 shares for $0.60 each. As a result, the insider received 2,411 and left with 135,725 shares of the company.
Valuation Measures:
As of this moment, CytomX’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.56.
Stock Price History:
Over the past 52 weeks, CTMX has reached a high of $4.94, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 48.85%, while the 200-Day Moving Average is calculated to be -1.05%.
Shares Statistics:
A total of 80.10M shares are outstanding, with a floating share count of 78.13M. Insiders hold about 2.46% of the company’s shares, while institutions hold 58.08% stake in the company.
